Neoadjuvant treatment strategies for hepatocellular carcinoma

被引：19
|
作者：
Xu, Lei [1 ]
Chen, Lin [1 ]
Zhang, Wei [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, 1095 Jie Fang Ave, Wuhan 430030, Hubei, Peoples R China
来源：
WORLD JOURNAL OF GASTROINTESTINAL SURGERY | 2021年 / 13卷 / 12期
关键词：
Hepatocellular carcinoma; Neoadjuvant therapy; Prognosis; Indications; Contraindications; PORTAL-VEIN EMBOLIZATION; DRUG-ELUTING BEADS; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; GEMCITABINE PLUS OXALIPLATIN; RECURRENCE-FREE SURVIVAL; FATTY LIVER-DISEASE; INFERIOR VENA-CAVA; TRANSARTERIAL CHEMOEMBOLIZATION; Y-90; RADIOEMBOLIZATION; CONVENTIONAL CHEMOEMBOLIZATION;
D O I：
10.4240/wjgs.v13.i12.1550
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The incidence of hepatocellular carcinoma (HCC) remains high globally. Surgical treatment is the best treatment for improving the prognosis of patients with HCC. Neoadjuvant therapy plays a key role in preventing tumor progression and even downstaging HCC. The liver transplantation rate and resectability rate have increased for neoadjuvant therapy. Neoadjuvant therapy is effective in different stages of HCC. In this review, we summarized the definition, methods, effects, indications and contraindications of neoadjuvant therapy in HCC, which have significance for guiding treatment.
引用
收藏
页码：1550 / 1566
页数：17
相关论文
共 50 条
  • [1] Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
    Akateh, Clifford
    Black, Sylvester M.
    Conteh, Lanla
    Miller, Eric D.
    Noonan, Anne
    Elliott, Eric
    Pawlik, Timothy M.
    Tsung, Allan
    Cloyd, Jordan M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (28) : 3704 - 3721
  • [2] Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
    Clifford Akateh
    Sylvester M Black
    Lanla Conteh
    Eric D Miller
    Anne Noonan
    Eric Elliott
    Timothy M Pawlik
    Allan Tsung
    Jordan M Cloyd
    World Journal of Gastroenterology, 2019, 25 (28) : 3704 - 3721
  • [3] Current locoregional therapies and treatment strategies in hepatocellular carcinoma
    Cardarelli-Leite, L.
    Hadjivassiliou, A.
    Klass, D.
    Chung, J.
    Ho, S. G. F.
    Lim, H. J.
    Kim, P. T. W.
    Mujoomdar, A.
    Liu, D. M.
    CURRENT ONCOLOGY, 2020, 27 : S144 - S151
  • [4] Neoadjuvant therapy and immunotherapy strategies for hepatocellular carcinoma
    Zhang, Ting
    Zhang, Lei
    Xu, Yiyao
    Lu, Xin
    Zhao, Haitao
    Yang, Huayu
    Sang, Xinting
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (06): : 1658 - 1667
  • [5] Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review
    Yang, Biao
    Liang, Jie
    Qu, Ziyu
    Yang, FangYun
    Liao, ZhengYin
    Gou, HongFeng
    PLOS ONE, 2020, 15 (02):
  • [6] Neoadjuvant Therapy for Hepatocellular Carcinoma
    Yin, Zongyi
    Chen, Dongying
    Liang, Shuang
    Li, Xiaowu
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 929 - 946
  • [7] Neoadjuvant and adjuvant systemic treatment for hepatocellular carcinoma
    Mathias-Machado, Maria Cecilia
    da Fonseca, Leonardo G.
    HEPATOMA RESEARCH, 2021, 7
  • [8] Current Treatment Methods in Hepatocellular Carcinoma
    Krupa, Kamila
    Fudalej, Marta
    Cencelewicz-Lesikow, Anna
    Badowska-Kozakiewicz, Anna
    Czerw, Aleksandra
    Deptala, Andrzej
    CANCERS, 2024, 16 (23)
  • [9] Treatment of Hepatocellular Carcinoma
    Liccioni, Alexandre
    Reig, Maria
    Bruix, Jordi
    DIGESTIVE DISEASES, 2014, 32 (05) : 554 - 563
  • [10] Treatment strategies for hepatocellular carcinoma in Japan
    Yamashita, Tatsuya
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2013, 43 (01) : 44 - 50
12345